Ra Capital Management, L.P., 10% owner at Hemab Therapeutics, bought COAG on Jun 16, 2026
Prices as of Oct 1 · price update delayed · Every feed →
▲ BUY$1.5M61,523 shares at $24.98Ra Capital Management, L.P. 10% ownerCOAG Hemab Therapeutics Holdings, Inc.
- Traded
- Jun 16, 2026
- Disclosed
- Jun 17, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
COAG since disclosure
+17.4%
Similar stocks (SPY) since disclosure
+3.1%
S&P 500 (SPY)
Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 1, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYRA Capital Healthcare Fund LP 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$1.5Mdisclosed Jun 17 · filed 1 day after the trade
- ▲ BUYPeter Kolchinsky 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$1.5Mdisclosed Jun 17 · filed 1 day after the trade
- ▲ BUYRajeev M. Shah 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$1.5Mdisclosed Jun 17 · filed 1 day after the trade
- ▲ BUYPeter Kolchinsky 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$153Kdisclosed Jun 17 · filed 2 days after the trade
- ▲ BUYRa Capital Management, L.P. 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$153Kdisclosed Jun 17 · filed 2 days after the trade
- ▲ BUYRajeev M. Shah 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$153Kdisclosed Jun 17 · filed 2 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP 10% ownerCOAG Hemab Therapeutics Holdings, Inc.$153Kdisclosed Jun 17 · filed 2 days after the trade